InflaRx NV buy Guggenheim
Start price
20.03.26
/
50%
€0.83
Target price
20.03.27
€12.10
Performance (%)
166.51%
Price
08.05.26
€2.21
Summary
This prediction is currently active. The BUY prediction by Guggenheim for InflaRx NV has seen massive gains of 166.51%. This prediction currently runs until 20.03.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| InflaRx NV | 25.113% | 25.113% |
| iShares Core DAX® | 0,22 % | 1,49 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % |
| iShares S&P 500 | 2,17 % | 8,06 % |
Comments by Guggenheim for this prediction
In the thread InflaRx NV diskutieren
InflaRx (IFRX) had its price target lowered by Guggenheim from $22.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for IFRX provided by MarketBeat